Histone Deacetylase Inhibitors Promote the Tumoricidal Effect of HAMLETBREST, Patrick; GUSTAFSSON, Mattias; MOSSBERG, Ann-Kristin et al.Cancer research (Baltimore). 2007, Vol 67, Num 23, pp 11327-11334, issn 0008-5472, 8 p.Article

Radiosensitization by the Histone Deacetylase Inhibitor PCI-24781BANUELOS, Carmen A; BANATH, Judit P; MACPHAIL, Susan H et al.Clinical cancer research. 2007, Vol 13, Num 22, pp 6816-6826, issn 1078-0432, 11 p., 1Article

FK228 (depsipeptide) : a HDAC inhibitor with pleiotropic antitumor activitiesKONSTANTINOPOULOS, Panagiotis A; VANDOROS, Gerasimos P; PAPAVASSILIOU, Athanasios G et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 5, pp 711-715, issn 0344-5704, 5 p.Article

HDAC inhibitor-based therapies and haematological malignancySTIMSON, L; WOOD, V; KHAN, O et al.Annals of oncology. 2009, Vol 20, Num 8, pp 1293-1302, issn 0923-7534, 10 p.Article

Histone Deacetylase Inhibitor Enhances Recovery after AKICIANCIOLO COSENTINO, Chiara; SKRYPNYK, Nataliya I; DAVIDSON, Alan J et al.Journal of the American Society of Nephrology. 2013, Vol 24, Num 6, pp 943-953, issn 1046-6673, 11 p.Article

Romidepsin for Cutaneous T-cell LymphomaMILES PRINCE, H; DICKINSON, Michael.Clinical cancer research (Print). 2012, Vol 18, Num 13, pp 3509-3515, issn 1078-0432, 7 p.Article

Identification of type-specific anticancer histone deacetylase inhibitors: road to successNOUREEN, Nighat; RASHID, Hamid; KALSOOM, Saima et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 4, pp 625-633, issn 0344-5704, 9 p.Article

Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophilsISHIHARA, Kenji; HONG, Jangja; ZEE, Okpyo et al.British journal of pharmacology. 2004, Vol 142, Num 6, pp 1020-1030, issn 0007-1188, 11 p.Article

Structure of HDAC3 bound to co-repressor and inositol tetraphosphateWATSON, Peter J; FAIRALL, Louise; SANTOS, Guilherme M et al.Nature (London). 2012, Vol 481, Num 7381, pp 335-340, issn 0028-0836, 6 p.Article

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDACMITHRAPRABHU, Sridurga; KHONG, Tiffany; JONES, Simon S et al.British journal of haematology. 2013, Vol 162, Num 4, pp 559-562, issn 0007-1048, 4 p.Article

HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic painDENK, Franziska; WENLONG HUANG; MCMAHON, Stephen B et al.Pain (Amsterdam). 2013, Vol 154, Num 9, pp 1668-1679, issn 0304-3959, 12 p.Article

Towards Histone Deacetylase Inhibitors as New Antimalarial DrugsANDREWS, Katherine T; TRAN, Thanh N; FAIRLIE, David P et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 24, pp 3467-3479, issn 1381-6128, 13 p.Article

Class II histone deacetylases are associated with VHL-lndependent regulation of hypoxia-inducible factor 1αQIAN, David Z; KACHHAP, Sushant K; COLLIS, Spencer J et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8814-8821, issn 0008-5472, 8 p.Article

Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignanciesYONG, W. P; GOH, B. C; LIM, D et al.Annals of oncology. 2011, Vol 22, Num 11, pp 2516-2522, issn 0923-7534, 7 p.Article

Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primatesWARREN, Katherine E; MCCULLY, Cindy; DVINGE, Henrik et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 3, pp 433-437, issn 0344-5704, 5 p.Article

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumoursRAZAK, Ara; HOTTE, S. J; ZHU, J et al.British journal of cancer. 2011, Vol 104, Num 5, pp 756-762, issn 0007-0920, 7 p.Article

Histone deacetylase inhibition as an anticancer telomerase-targeting strategyRAHMAN, Ruman; GRUNDY, Richard.International journal of cancer (Print). 2011, Vol 129, Num 12, pp 2765-2774, issn 0020-7136, 10 p.Article

Chemical Origins of Isoform Selectivity in Histone Deacetylase Inhibitors : Histone Deacetylase InhibitorsBUTLER, Kyle V; KOZIKOWSKI, Alan P.Current pharmaceutical design. 2008, Vol 14, Num 6, pp 505-528, issn 1381-6128, 24 p.Article

Sirtuin ModulatorsMAHAJAN, Sumit S; LEKO, Vid; SIMON, Julian A et al.Handbook of experimental pharmacology. 2011, Vol 206, pp 241-255, issn 0171-2004, 15 p.Article

The Critical Role of the Class III Histone Deacetylase SIRT1 in CancerTAO LIU; LIU, Pei Y; MARSHALL, Glenn M et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 5, pp 1702-1705, issn 0008-5472, 4 p.Article

Histone deacetylase inhibitors in the treatment for multiple myeloma : PIH: Basic and Clinical Updates in Multiple MyelomaHIDESHIMA, Teru; ANDERSON, Kenneth C.International journal of hematology. 2013, Vol 97, Num 3, pp 324-332, issn 0925-5710, 9 p.Article

Chromatin modifier enzymes, the histone code and cancerSANTOS-ROSA, Helena; CALDAS, Carlos.European journal of cancer (1990). 2005, Vol 41, Num 16, pp 2381-2402, issn 0959-8049, 22 p.Article

Mechanisms of HDAC inhibitor-induced thrombocytopeniaMATSUOKA, Hideaki; UNAMI, Akira; FUJIMURA, Takao et al.European journal of pharmacology. 2007, Vol 571, Num 2-3, pp 88-96, issn 0014-2999, 9 p.Article

Pharmacology of epigenetics in brain disordersNARAYAN, Pritika; DRAGUNOW, Mike.British journal of pharmacology. 2010, Vol 159, Num 2, pp 285-303, issn 0007-1188, 19 p.Article

Inhibition of histone deacetylase causes reduction of appressorium formation in the rice blast fungus Magnaporthe oryzaeIZAWA, Masumi; TAKEKAWA, Osamu; ARIE, Tsutomu et al.Journal of General and Applied Microbiology. 2009, Vol 55, Num 6, pp 489-498, issn 0022-1260, 10 p.Article